Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group.

Neurology. 2018 Dec 26. pii: 10.1212/WNL.0000000000006810. doi: 10.1212/WNL.0000000000006810. [Epub ahead of print] Review.

PMID:
30587516
2.

Multiple sclerosis in 2018: new therapies and biomarkers.

Ciccarelli O.

Lancet Neurol. 2019 Jan;18(1):10-12. doi: 10.1016/S1474-4422(18)30455-1. No abstract available.

PMID:
30563672
3.

Tumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administration.

Ciccarelli O, Colson A, De Saeger C, Reding R, Sempoux C, Leclercq IA, Stärkel P.

Onco Targets Ther. 2018 Oct 17;11:7143-7153. doi: 10.2147/OTT.S176903. eCollection 2018.

4.

Tacrolimus and Single Intraoperative High-dose of Anti-T-lymphocyte Globulins Versus Tacrolimus Monotherapy in Adult Liver Transplantation: One-year Results of an Investigator-driven Randomized Controlled Trial.

Iesari S, Ackenine K, Foguenne M, De Reyck C, Komuta M, Bonaccorsi Riani E, Ciccarelli O, Coubeau L, Lai Q, Gianello P, Lerut J.

Ann Surg. 2018 Nov;268(5):776-783. doi: 10.1097/SLA.0000000000002943.

PMID:
30307410
5.

Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks.

Gros C, De Leener B, Badji A, Maranzano J, Eden D, Dupont SM, Talbott J, Zhuoquiong R, Liu Y, Granberg T, Ouellette R, Tachibana Y, Hori M, Kamiya K, Chougar L, Stawiarz L, Hillert J, Bannier E, Kerbrat A, Edan G, Labauge P, Callot V, Pelletier J, Audoin B, Rasoanandrianina H, Brisset JC, Valsasina P, Rocca MA, Filippi M, Bakshi R, Tauhid S, Prados F, Yiannakas M, Kearney H, Ciccarelli O, Smith S, Treaba CA, Mainero C, Lefeuvre J, Reich DS, Nair G, Auclair V, McLaren DG, Martin AR, Fehlings MG, Vahdat S, Khatibi A, Doyon J, Shepherd T, Charlson E, Narayanan S, Cohen-Adad J.

Neuroimage. 2019 Jan 1;184:901-915. doi: 10.1016/j.neuroimage.2018.09.081. Epub 2018 Oct 6.

PMID:
30300751
6.

Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages.

Melendez-Torres GJ, Armoiry X, Court R, Patterson J, Kan A, Auguste P, Madan J, Counsell C, Ciccarelli O, Clarke A.

BMC Neurol. 2018 Oct 3;18(1):162. doi: 10.1186/s12883-018-1162-9. Review.

7.

Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.

Brownlee WJ, Miszkiel KA, Tur C, Barkhof F, Miller DH, Ciccarelli O.

Neurology. 2018 Sep 18;91(12):e1130-e1134. doi: 10.1212/WNL.0000000000006207. Epub 2018 Aug 17.

PMID:
30120132
8.

Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Yes.

Cortese R, Ciccarelli O.

Mult Scler. 2018 Oct;24(12):1536-1537. doi: 10.1177/1352458518778010. Epub 2018 Jul 23. No abstract available.

PMID:
30033804
9.

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

Tur C, Eshaghi A, Altmann DR, Jenkins TM, Prados F, Grussu F, Charalambous T, Schmidt A, Ourselin S, Clayden JD, Wheeler-Kingshott CAMG, Thompson AJ, Ciccarelli O, Toosy AT.

Sci Rep. 2018 Jul 16;8(1):10715. doi: 10.1038/s41598-018-29017-1.

10.

Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study.

Hagens MHJ, Burggraaff J, Kilsdonk ID, de Vos ML, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Ciccarelli O, Gasperini C, Lukas C, Wattjes MP, Barkhof F; MAGNIMS Study Group.

Neurology. 2018 Jul 17;91(3):e249-e257. doi: 10.1212/WNL.0000000000005825. Epub 2018 Jun 20.

11.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

12.

Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome.

Eyre M, Hameed A, Wright S, Brownlee W, Ciccarelli O, Bowman R, Lim M, Wassmer E, Thompson D, Hemingway C, Hacohen Y.

Dev Med Child Neurol. 2018 Dec;60(12):1244-1250. doi: 10.1111/dmcn.13757. Epub 2018 Apr 11.

PMID:
29637998
13.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
14.

Multiple sclerosis.

Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O.

Lancet. 2018 Apr 21;391(10130):1622-1636. doi: 10.1016/S0140-6736(18)30481-1. Epub 2018 Mar 23. Review.

PMID:
29576504
15.

The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis.

Schoonheim MM, Ciccarelli O.

Neurology. 2018 Apr 10;90(15):677-678. doi: 10.1212/WNL.0000000000005279. Epub 2018 Mar 14. No abstract available.

PMID:
29540583
16.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
17.

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.

Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, Yiannakas MC, Prados F, Ourselin S, Yousry TA, Barkhof F, Ciccarelli O.

Neurology. 2018 Apr 3;90(14):e1183-e1190. doi: 10.1212/WNL.0000000000005256. Epub 2018 Mar 7.

PMID:
29514948
18.

Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.

Duignan S, Wright S, Rossor T, Cazabon J, Gilmour K, Ciccarelli O, Wassmer E, Lim M, Hemingway C, Hacohen Y.

Dev Med Child Neurol. 2018 Sep;60(9):958-962. doi: 10.1111/dmcn.13703. Epub 2018 Feb 22.

PMID:
29468668
19.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group.

Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808. No abstract available.

PMID:
29451440
20.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

21.

Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.

Hagens MH, Burggraaff J, Kilsdonk ID, Ruggieri S, Collorone S, Cortese R, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Wuerfel J, Ciccarelli O, Gasperini C, Lukas C, Rovira A, Barkhof F, Wattjes MP; MAGNIMS Study Group.

Mult Scler. 2018 Jan 1:1352458517751647. doi: 10.1177/1352458517751647. [Epub ahead of print]

PMID:
29327668
22.

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Tur C, Moccia M, Barkhof F, Chataway J, Sastre-Garriga J, Thompson AJ, Ciccarelli O.

Nat Rev Neurol. 2018 Feb;14(2):75-93. doi: 10.1038/nrneurol.2017.171. Epub 2018 Jan 12. Review.

PMID:
29326424
23.

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B, Kalser J, Poulat AL, Maurey H, Ganelin-Cohen E, Wassmer E, Hemingway C, Forsyth R, Hennes EM, Leite MI, Ciccarelli O, Anlar B, Hintzen R, Marignier R, Palace J, Baumann M, Rostásy K, Neuteboom R, Deiva K, Lim M.

JAMA Neurol. 2018 Apr 1;75(4):478-487. doi: 10.1001/jamaneurol.2017.4601.

24.

'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.

Hacohen Y, Rossor T, Mankad K, Chong W', Lux A, Wassmer E, Lim M, Barkhof F, Ciccarelli O, Hemingway C.

Dev Med Child Neurol. 2018 Apr;60(4):417-423. doi: 10.1111/dmcn.13649. Epub 2017 Dec 30.

PMID:
29288492
25.

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA.

Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21.

PMID:
29275979
26.

Cortico-juxtacortical and periventricular lesions and MS diagnostic criteria.

Svenningsson A, Ciccarelli O.

Neurology. 2017 Dec 5;89(23):2308-2309. doi: 10.1212/WNL.0000000000004725. Epub 2017 Nov 3. No abstract available.

PMID:
29101273
27.

Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.

Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.

Brain. 2017 Nov 1;140(11):2927-2938. doi: 10.1093/brain/awx228.

28.

Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.

Hacohen Y, Ciccarelli O, Hemingway C.

Brain. 2017 May 1;140(5):1172-1174. doi: 10.1093/brain/awx075. No abstract available.

PMID:
29050372
29.

Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.

Melendez-Torres GJ, Auguste P, Armoiry X, Maheswaran H, Court R, Madan J, Kan A, Lin S, Counsell C, Patterson J, Rodrigues J, Ciccarelli O, Fraser H, Clarke A.

Health Technol Assess. 2017 Sep;21(52):1-352. doi: 10.3310/hta21520. Review.

30.

Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study.

de Sitter A, Steenwijk MD, Ruet A, Versteeg A, Liu Y, van Schijndel RA, Pouwels PJW, Kilsdonk ID, Cover KS, van Dijk BW, Ropele S, Rocca MA, Yiannakas M, Wattjes MP, Damangir S, Frisoni GB, Sastre-Garriga J, Rovira A, Enzinger C, Filippi M, Frederiksen J, Ciccarelli O, Kappos L, Barkhof F, Vrenken H; MAGNIMS study group and for neuGRID.

Neuroimage. 2017 Dec;163:106-114. doi: 10.1016/j.neuroimage.2017.09.011. Epub 2017 Sep 9.

PMID:
28899746
31.

Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

Wiendl H, Bourdette D, Ciccarelli O.

Neurology. 2017 Sep 12;89(11):1098-1100. doi: 10.1212/WNL.0000000000004381. Epub 2017 Aug 23. No abstract available.

PMID:
28835406
32.

Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody.

Hacohen Y, Messina S, Gan HW, Wright S, Chandratre S, Leite MI, Fallon P, Vincent A, Ciccarelli O, Wassmer E, Lim M, Palace J, Hemingway C.

Mult Scler. 2018 Apr;24(5):679-684. doi: 10.1177/1352458517726593. Epub 2017 Aug 14.

PMID:
28803524
33.

Sensitivity of multi-shell NODDI to multiple sclerosis white matter changes: a pilot study.

Schneider T, Brownlee W, Zhang H, Ciccarelli O, Miller DH, Wheeler-Kingshott CG.

Funct Neurol. 2017 Apr/Jun;32(2):97-101.

34.

Message from the Editors to our Reviewers.

Gross RA, Worrall BB, Amato AA, Cascino GD, Ciccarelli O, Corboy JR, Dalmau JO, Gottesman RF, Grossman M, Millichap JJ, Mink JW, Pulst SM, Uitti RJ.

Neurology. 2017 Jul 4;89(1):2-10. doi: 10.1212/WNL.0000000000004104. No abstract available.

PMID:
28674154
35.

A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).

Absoud M, Brex P, Ciccarelli O, Diribe O, Giovannoni G, Hellier J, Howe R, Holland R, Kelly J, McCrone P, Murphy C, Palace J, Pickles A, Pike M, Robertson N, Jacob A, Lim M.

Health Technol Assess. 2017 May;21(31):1-50. doi: 10.3310/hta21310.

36.

Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.

Hacohen Y, Mankad K, Chong WK, Barkhof F, Vincent A, Lim M, Wassmer E, Ciccarelli O, Hemingway C.

Neurology. 2017 Jul 18;89(3):269-278. doi: 10.1212/WNL.0000000000004117. Epub 2017 Jun 14.

PMID:
28615429
37.

Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.

Cawley N, Tur C, Prados F, Plantone D, Kearney H, Abdel-Aziz K, Ourselin S, Wheeler-Kingshott CAG, Miller DH, Thompson AJ, Ciccarelli O.

Mult Scler. 2018 Jun;24(7):932-941. doi: 10.1177/1352458517709954. Epub 2017 May 18.

PMID:
28516804
38.

Author response: Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.

Eshaghi A, Ciccarelli O.

Neurology. 2017 May 9;88(19):1875. doi: 10.1212/WNL.0000000000003930. No abstract available.

PMID:
28483994
39.

Molecular and Metabolic Imaging in Multiple Sclerosis.

Moccia M, Ciccarelli O.

Neuroimaging Clin N Am. 2017 May;27(2):343-356. doi: 10.1016/j.nic.2016.12.005. Review.

PMID:
28391791
40.

11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.

Datta G, Colasanti A, Kalk N, Owen D, Scott G, Rabiner EA, Gunn RN, Lingford-Hughes A, Malik O, Ciccarelli O, Nicholas R, Nei L, Battaglini M, Stefano ND, Matthews PM.

J Nucl Med. 2017 Sep;58(9):1477-1482. doi: 10.2967/jnumed.116.187161. Epub 2017 Mar 16.

41.

Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.

Giovannoni G, Cutter G, Sormani MP, Belachew S, Hyde R, Koendgen H, Knappertz V, Tomic D, Leppert D, Herndon R, Wheeler-Kingshott CAM, Ciccarelli O, Selwood D, di Cantogno EV, Ben-Amor AF, Matthews P, Carassiti D, Baker D, Schmierer K.

Mult Scler Relat Disord. 2017 Feb;12:70-78. doi: 10.1016/j.msard.2017.01.007. Epub 2017 Jan 17. Review.

PMID:
28283111
42.

Machine learning based compartment models with permeability for white matter microstructure imaging.

Nedjati-Gilani GL, Schneider T, Hall MG, Cawley N, Hill I, Ciccarelli O, Drobnjak I, Wheeler-Kingshott CAMG, Alexander DC.

Neuroimage. 2017 Apr 15;150:119-135. doi: 10.1016/j.neuroimage.2017.02.013. Epub 2017 Feb 8.

43.

Longitudinal multiple sclerosis lesion segmentation: Resource and challenge.

Carass A, Roy S, Jog A, Cuzzocreo JL, Magrath E, Gherman A, Button J, Nguyen J, Prados F, Sudre CH, Jorge Cardoso M, Cawley N, Ciccarelli O, Wheeler-Kingshott CAM, Ourselin S, Catanese L, Deshpande H, Maurel P, Commowick O, Barillot C, Tomas-Fernandez X, Warfield SK, Vaidya S, Chunduru A, Muthuganapathy R, Krishnamurthi G, Jesson A, Arbel T, Maier O, Handels H, Iheme LO, Unay D, Jain S, Sima DM, Smeets D, Ghafoorian M, Platel B, Birenbaum A, Greenspan H, Bazin PL, Calabresi PA, Crainiceanu CM, Ellingsen LM, Reich DS, Prince JL, Pham DL.

Neuroimage. 2017 Mar 1;148:77-102. doi: 10.1016/j.neuroimage.2016.12.064. Epub 2017 Jan 11.

44.

Is the early course of multiple sclerosis the same in adults and children?

Brownlee WJ, Ciccarelli O.

Eur J Neurol. 2017 Feb;24(2):235-236. doi: 10.1111/ene.13230. Epub 2016 Dec 21. No abstract available.

PMID:
28000320
45.

Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.

Datta G, Violante IR, Scott G, Zimmerman K, Santos-Ribeiro A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Matthews PM.

Mult Scler. 2017 Oct;23(11):1469-1478. doi: 10.1177/1352458516681504. Epub 2016 Dec 7.

46.

The Use of Autologous Peritoneum for Complete Caval Replacement Following Resection of Major Intra-abdominal Malignancies.

Coubeau L, Rico Juri JM, Ciccarelli O, Jabbour N, Lerut J.

World J Surg. 2017 Apr;41(4):1005-1011. doi: 10.1007/s00268-016-3804-7.

PMID:
27826769
47.

Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.

Eshaghi A, Wottschel V, Cortese R, Calabrese M, Sahraian MA, Thompson AJ, Alexander DC, Ciccarelli O.

Neurology. 2016 Dec 6;87(23):2463-2470. Epub 2016 Nov 2.

48.

Fully automated grey and white matter spinal cord segmentation.

Prados F, Cardoso MJ, Yiannakas MC, Hoy LR, Tebaldi E, Kearney H, Liechti MD, Miller DH, Ciccarelli O, Wheeler-Kingshott CA, Ourselin S.

Sci Rep. 2016 Oct 27;6:36151. doi: 10.1038/srep36151.

49.

Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.

Brownlee WJ, Miszkiel KA, Altmann DR, Ciccarelli O, Miller DH.

Mult Scler. 2017 Jun;23(7):1031-1034. doi: 10.1177/1352458516667565. Epub 2016 Sep 6.

50.

Reconstruction of an abdominal wall defect with biologic mesh after resection of a desmoid tumor in a patient with a Gardner's syndrome.

Hammer J, Léonard D, Chateau F, Abbes Orabi N, Ciccarelli O, Bachmann R, Remue C, Lengelé B, Kartheuser A.

Acta Chir Belg. 2017 Feb;117(1):55-60. doi: 10.1080/00015458.2016.1212499. Epub 2016 Aug 18.

PMID:
27538186

Supplemental Content

Loading ...
Support Center